Ryan Zeidan, PhD

President and CEO

Dr.  Zeidan is the President and CEO of Sling Therapeutics, Inc.

Dr. Zeidan was previously the Chief Development Officer at Millendo Therapeutics, as well as various positions at Celgene and Novartis. He has led research and development activities for late-stage assets, including rare diseases, oncology and vaccines. Dr. Zeidan is experienced in management of Regulatory, Clinical Operations, CMC, Project Management, Clinical Development, and Medical Affairs.

Dr. Zeidan holds a BS in Chemistry and Chemical Engineering from Massachusetts Institute of Technology and a PhD in Chemistry from The California Institute of Technology.